Kura Oncology, Inc. - Common Stock (KURA)

CUSIP: 50127T109

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / Common Stock
Shares outstanding
87,054,674
Total 13F shares
9,748,853
Share change
+440,201
Total reported value
$60,931,000
Price per share
$6.25
Number of holders
25
Value change
+$2,850,289
Number of buys
14
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 50127T109?
CUSIP 50127T109 identifies KURA - Kura Oncology, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of KURA - Kura Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
3.2%
2,815,919
$7,631,000 30 Jun 2016
13F
EcoR1 Capital, LLC
13F
Company
2.8%
2,465,286
$6,681,000 30 Jun 2016
13F
PFM Health Sciences, LP
13F
Company
1.9%
1,671,164
$4,529,000 30 Jun 2016
13F
CLOUGH CAPITAL PARTNERS L P
13F
Company
0.86%
748,039
$2,027,000 30 Jun 2016
13F
Boxer Capital, LLC
13F
Company
0.73%
633,692
$1,717,000 30 Jun 2016
13F
Minerva Advisors LLC
13F
Company
0.42%
361,737
$977,000 30 Jun 2016
13F
VANGUARD GROUP INC
13F
Company
0.34%
294,166
$797,000 30 Jun 2016
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.07%
63,000
$171,000 30 Jun 2016
13F
ALETHEA CAPITAL MANAGEMENT, LLC
13F
Company
0.07%
62,000
$168,000 30 Jun 2016
13F
Birchview Capital, LP
13F
Company
0.07%
59,114
$160,000 30 Jun 2016
13F
BlackRock Fund Advisors
13F
Company
0.04%
35,220
$95,000 30 Jun 2016
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.03%
23,800
$64,000 30 Jun 2016
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.03%
23,500
$64,000 30 Jun 2016
13F
Partner Investment Management, L.P.
13F
Company
0.03%
23,023
$62,000 30 Jun 2016
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.02%
13,300
$36,000 30 Jun 2016
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
10,390
$28,000 30 Jun 2016
13F
CITIGROUP INC
13F
Company
0.01%
5,350
$14,000 30 Jun 2016
13F
BlackRock Investment Management, LLC
13F
Company
0%
2,529
$7,000 30 Jun 2016
13F
MUFG Americas Holdings Corp
13F
Company
0%
1,675
$5,000 30 Jun 2016
13F
MORGAN STANLEY
13F
Company
0%
1,600
$4,000 30 Jun 2016
13F
DEUTSCHE BANK AG\
13F
Company
0%
1,352
$3,000 30 Jun 2016
13F
BlackRock Japan Co. Ltd
13F
Company
0%
1,204
$3,000 30 Jun 2016
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0%
904
$2,000 30 Jun 2016
13F
BLACKROCK ADVISORS LLC
13F
Company
0%
768
$2,000 30 Jun 2016
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
310
$1,000 30 Jun 2016
13F

Institutional Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q3 2016

As of 30 Sep 2016, Kura Oncology, Inc. - Common Stock (KURA) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,748,853 shares. The largest 10 holders included FMR LLC, EcoR1 Capital, LLC, Partner Fund Management, L.P., Clough Capital Partners L P, Boxer Capital, LLC, VANGUARD GROUP INC, Minerva Advisors LLC, Alethea Capital Management, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, and Birchview Capital, LP. This page lists 25 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2016 vs Q2 2016 Across Filers

Q2 2016 holders
25
Q3 2016 holders
25
Holder diff
0
Investor Q2 2016 Shares Q3 2016 Shares Share Diff Share Chg % Q2 2016 Value $ Q3 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.